Stem Cell Mobilization Characteristics for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) Treated with Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab (KRd-Dara)

Blood(2022)

引用 0|浏览12
暂无评分
关键词
multiple myeloma,stem cell mobilization characteristics,transplant eligible patients,lenalidomide,krd-dara
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要